The grey matter in the brain may hold vital clues for early, accurate detection in Alzheimer’s, and potentially also help pharma to find new drug treatments.
Oxford Brain Diagnostic’s Dr Steven Chance explains the importance of early detection of dementia for treatment and research, and why new measurements of neurodegeneration are needed.
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl